ursodeoxycholic acid has been researched along with Asthma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchan, GJ; Cechova, V; Ellgass, M; Fajt, ML; Freeman, BA; Hart, R; Heinrich, VA; Holguin, F; Koudelka, A; Manni, ML; Mullett, SJ; O'Brien, JP; Oury, TD; Rawas-Qalaji, M; Ukani, D; Uvalle, C; Wendell, SG; Wenzel, SE | 1 |
| Grefhorst, A; Hammad, H; Hoogsteden, HC; Kleinjan, A; Lambrecht, BN; Moons, L; van Nimwegen, M; Willart, MA | 1 |
2 other study(ies) available for ursodeoxycholic acid and Asthma
| Article | Year |
|---|---|
Nitroalkene fatty acids modulate bile acid metabolism and lung function in obese asthma.
Topics: Adolescent; Adult; Animals; Anti-Asthmatic Agents; Antigens, Dermatophagoides; Asthma; Bile Acids and Salts; Diet, High-Fat; Drug Evaluation, Preclinical; Fatty Acids; Female; Forced Expiratory Volume; Glycocholic Acid; Humans; Liver; Lung; Male; Mice; Mice, Inbred C57BL; Middle Aged; Nitro Compounds; Obesity; Oleic Acids; Respiratory Hypersensitivity; Thinness; Ursodeoxycholic Acid; Vital Capacity; Young Adult | 2021 |
Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor.
Topics: Animals; Asthma; Cell Communication; Cell Survival; Cytokines; Dendritic Cells; Disease Models, Animal; Eosinophils; Female; Immunologic Factors; Inflammation; Mice; Mice, Knockout; Pulmonary Eosinophilia; Receptors, Cytoplasmic and Nuclear; T-Lymphocytes; Th1 Cells; Ursodeoxycholic Acid | 2012 |